Patient Voice, • 9/19/25 Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Previous Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Next Leveraging Patient Advocacy To Scale Rare Disease Trials You Might Also Like How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications How To Prevent Failure in Rare Disease Trials? Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials
Patient Voice, • 9/19/25 Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Previous Decentralized by Design: Operationalizing Hybrid Rare Disease Trials Next Leveraging Patient Advocacy To Scale Rare Disease Trials You Might Also Like How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications How To Prevent Failure in Rare Disease Trials? Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories Patient Recruitment and Engagement in in Global, Multisite Rare Disease Trials
